Dr Jagadish Hiremath, a public health intellectual, says, “The normalisation of GLP-1 agonists like Ozempic and Wegovy as ...

GLP-1 medications like Semaglutide (found in Ozempic and Wegovy) and Tirzepatide (found in Mounjaro) mimic the body’s natural ...

Amazon may be known for its retail and tech chops, but the company has also built a strong operation in the healthcare realm ...

Ozempic's meteoric rise has reshaped the landscape of healthcare, retail, and consumer behavior. Its initial popularity as a weight loss ...

Since 2018, about 350 pharmacies in Alabama closed their doors. That’s more than one a week. Now a coalition of independent ...

From online fitness trends to the abundance of wellness fads to hot new diets, you may feel defeated without even starting your weight-loss journey. But taking that first initial step is usually the ...

Drugs like Ozempic and Wegovy have skyrocketed in popularity over the past few years. To capitalize on that demand, telehealth companies started offering compounded versions of those drugs.

The Standard's journalism is supported by our readers. When you purchase through links on our site, we may earn an affiliate commission. A healthy diet and regular exercise are the two best tools ...

One study found that people who followed a Mediterranean or green Mediterranean diet had more weight loss and reduced waist circumference. A green Mediterranean diet focuses more on plant-based ...

The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the weight-loss drug Zepbound. The medicine, part of the class known as GLP-1 ...

Zepbound is the first prescription drug approved specifically to treat the common condition. By Dani Blum The Food and Drug Administration on Friday approved the weight loss drug Zepbound to treat ...

Dec 20 (Reuters) - The U.S. Food and Drug Administration on Friday approved Eli Lilly's (LLY.N), opens new tab weight-loss treatment, Zepbound, for obstructive sleep apnea, making it the first ...